Vulnerability · CVE-2020-37237
Composr CMS 10.0.34 contains a persistent cross-site scripting vulnerability that allows authenticated administrators to inject malicious scripts through the banner ma…
Published May 16, 2026 · catalog updated Sep 29, 2026 · the affected product
Check if you run it
No confirmed exploitation is on record for CVE-2020-37237. EPSS is 0.24%. Act only if a listed version of the affected product is installed.
Gaps on this record
- No plain product name is stored. The page cannot tell you which product to check.
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium5.1
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.24%
- Remediation
- Not established
- Affected products
- See sources for product scope
Composr CMS 10.0.34 contains a persistent cross-site scripting vulnerability that allows authenticated administrators to inject malicious scripts through the banner management interface. Attackers with admin credentials can inject XSS payloads in the Description field of the Add banner functionality, which execute for all website visitors when they access the home page.
No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.
How to fix CVE-2020-37237
Recommended remediation
No required-action text, fix commit, or clear fixed-version range is stored yet.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2020-37237. EPSS is 0.24%. Act only if a listed version of the affected product is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-79: Cross-site Scripting (XSS). EPSS 0.24%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
May 16, 2026 · NIST NVD
Detected
Composr CMS 10.0.34 contains a persistent cross-site scripting vulnerability that allows authenticated administrators to inject malicious scripts through the banner management interface. Attackers with admin credentials can inject XSS payloads in the Description field of the Add banner functionality, which execute for all website visitors when they access the home page.
Sep 29, 2026 · NIST NVD
Updated
Composr CMS 10.0.34 contains a persistent cross-site scripting vulnerability that allows authenticated administrators to inject malicious scripts through the banner management interface. Attackers with admin credentials can inject XSS payloads in the Description field of the Add banner functionality, which execute for all website visitors when they access the home page.
Sources
- CVE.orgVulnerability recordCVE-2020-37237
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2020-37237
30-day exploitation probability 0.2%
first.org - NIST NVDVulnerability recordCVE-2020-37237
Composr CMS 10.0.34 contains a persistent cross-site scripting vulnerability that allows authenticated administrators to inject malicious scripts through the banner management interface. Attackers with admin credentials can inject XSS payloads in the Description field of the Add
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 16, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.